Celanese Corp. (CE) Misses Q1 EPS by 1c; offers guidance
Get Alerts CE Hot Sheet
Price: $44.67 --0%
Revenue Growth %: +8.3%
Financial Fact:
Operating profit (loss): 246M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.3%
Financial Fact:
Operating profit (loss): 246M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Celanese Corp. (NYSE: CE) reported Q1 EPS of $0.85, $0.01 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $2.34 billion versus the consensus estimate of $2.34 billion.
GUIDANCE:
Celanese Corp. sees Q2 2026 EPS of $2.00-$2.40, versus the consensus of $1.69.
We are currently estimating adjusted earnings per share of approximately $3.00 per share in the second half of 2026 as we continue to advance actions to enhance our commercial capabilities and cost structure.\"
For earnings history and earnings-related data on Celanese Corp. (CE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Gorilla Technology begins equipment delivery for India AI program
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share